טוען...
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
OBJECTIVE: Most myeloma tumor cells from patients express NKG2D ligands. We have reported the development of a chimeric NKG2D receptor (chNKG2D), which consists of the NKG2D receptor fused to the CD3ζ chain. T cells expressing this receptor kill and produce cytokines in response to NKG2D-ligand+ tum...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2638591/ https://ncbi.nlm.nih.gov/pubmed/18599182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2008.04.010 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|